The present invention pertains to angioplasty and angioplasty balloon catheters. More particularly, the present invention pertains to angioplasty balloon catheters that include one or more cutting edges coupled to the angioplasty balloon.
Heart and vascular disease are major problems in the United States and throughout the world. Conditions such as atherosclerosis result in blood vessels becoming blocked or narrowed. This blockage can result in lack of oxygenation of the heart, which has significant consequences since the heart muscle must be well oxygenated in order to maintain its blood pumping action.
Occluded, stenotic, or narrowed blood vessels may be treated with a number of relatively non-invasive medical procedures including percutaneous transluminal angioplasty (PTA), percutaneous transluminal coronary angioplasty (PTCA), and atherectomy. Angioplasty techniques typically involve the use of a balloon catheter. The balloon catheter is advanced over a guidewire so that the balloon is positioned adjacent a stenotic lesion. The balloon is then inflated and the restriction of the vessel is opened.
One of the major obstacles in treating coronary artery disease and/or treating blocked blood vessels is re-stenosis. Evidence has shown that cutting the stenosis, for example, with an angioplasty balloon equipped with a cutting blade, during treatment can reduce incidence of re-stenosis. Additionally, cutting the stenosis may reduce trauma at the treatment site and/or may reduce the trauma to adjacent healthy tissue. Cutting blades may also be beneficial additions to angioplasty procedures when the targeted occlusion is hardened or calcified. It is believed typical angioplasty balloons, alone, may not be able to expand certain of these hardened lesions. Thus, angioplasty balloons equipped with cutting edges have been developed to attempt to enhance angioplasty treatments. There is an ongoing need for improved angioplasty devices, including cutting angioplasty balloons, and improved methods of treating intravascular stenoses and occlusions.
Another potential obstacle that may accompany treatments that include expansion of a stenosis with an angioplasty balloon is the removal of the balloon from the vessel. This is because when the balloon is deflated, it may tend to maintain a relatively large profile. Moreover, if the balloon includes a cutting edge, the potential exists for the cutting edge to be disposed at a large profile region of the balloon. This could subject healthy tissue to unnecessary contact with the cutting edge and resultant abrasion or cutting during the balloon removal procedure. Accordingly, there is an ongoing need for improved angioplasty devices, including cutting angioplasty balloons, with improved re-folding abilities.
The present invention relates to angioplasty balloon catheters. In at least some embodiments, an exemplary balloon catheter may include a catheter shaft having a balloon coupled thereto. The balloon may include one or more cutting members or blades. Additionally, the balloon may include a number of channels or chambers extending therethrough that may, for example, improve the folding and refolding abilities of the balloon and decrease balloon elongation. These and other features are described in more detail below.
The following description should be read with reference to the drawings wherein like reference numerals indicate like elements throughout the several views. The detailed description and drawings illustrate example embodiments of the claimed invention.
Angioplasty techniques that include the use of an angioplasty balloon with cutting blades attached thereto have been shown to be a desirable treatment modality for at least some intravascular interventions.
A partially cut-away perspective view of a portion of catheter 10 is shown in
In at least some embodiments, cavities 24 may be defined by a plurality of dividing sections 26 projecting radially inward from the interior wall of balloon 16. Sections 26 may be attached to, be integral with, or otherwise be coupled to balloon 16 and may extend between the interior wall of the balloon 16 and a central balloon tubular portion 31 which forms a lumen 32 adjacent the shaft 18. In some embodiments, shaft 18 may include an inner tubular member 28 and an outer tubular member 30 (more clearly seen in
Balloon 16 may be made from typical angioplasty balloon materials including polymers such as polyethylene terephthalate (PET), polyetherimid (PEI), polyethylene (PE), etc. Some other examples of suitable polymers may include polytetrafluoroethylene (PTFE), ethylene tetrafluoroethylene (ETFE), fluorinated ethylene propylene (FEP), polyoxymethylene (POM), polybutylene terephthalate (PBT), polyether block ester, polyurethane, polypropylene (PP), polyvinylchloride (PVC), polyether-ester (for example, a polyether-ester elastomer such as ARNITEL® available from DSM Engineering Plastics), polyester (for example, a polyester elastomer such as HYTREL® available from DuPont), polyamide (for example, DURETHAN® available from Bayer or CRISTAMID® available from Elf Atochem), elastomeric polyamides, block polyamide/ethers, polyether block amide (PEBA, for example, available under the trade name PEBAX®), silicones, Marlex high-density polyethylene, Marlex low-density polyethylene, linear low density polyethylene (for example, REXELL®), polyetheretherketone (PEEK), polyimide (PI), polyphenylene sulfide (PPS), polyphenylene oxide (PPO), polysulfone, nylon, perfluoro(propyl vinyl ether) (PFA), other suitable materials, or mixtures, combinations, copolymers thereof, polymer/metal composites, and the like.
In some embodiments, it may be desirable to use high modulus or generally stiffer materials so as to reduce balloon elongation. The above list of materials includes some examples of higher modulus materials. Some other examples of stiffer materials include polymers blended with liquid crystal polymer (LCP) as well as the materials listed above. For example, the mixture can contain up to about 5% LCP. Additionally, due to the relative inelasticity of cutting members 20, balloon elongation could create shear forces between cutting members 20 and balloon 16. Thus, reducing balloon elongation may also help maintain the integrity of the coupling between balloon 16 and cutting members 20. By including channels 24 in balloon 16, it has been found possible to more precisely control the inflation, folding and refolding of balloon 16. For example, channels 24 can allow balloon 16 to be inflated more evenly, which may reduce balloon elongation. Because balloon elongation can be reduced by including channels 24, it is possible to manufacture balloon 16 from lower modulus materials, which may be easier to refold than stiffer materials.
Another cross-sectional view of catheter 10 is shown in
Tubular members 28/30 may be arranged in any appropriate way. For example, in some embodiments inner tubular member 28 can be disposed coaxially within outer tubular member 30. According to these embodiments, inner and outer tubular members 28/30 may or may not be secured to one another along the general longitudinal axis of catheter shaft 18. Alternatively, inner tubular member 28 may follow the inner wall or otherwise be disposed adjacent the inner wall of outer tubular member 30. Again, inner and outer tubular members 28/30 may or may not be secured to one another. For example, inner and outer tubular members 28/30 may be bonded, welded (including tack welding or any other welding technique), or otherwise secured at a bond point. In some embodiments, the bond point may be generally disposed near the distal end of catheter shaft 18. However, one or more bond points may be disposed at any position along shaft 18. The bond may desirably impact, for example, the stability and the ability of tubular members 28/30 to maintain their position relative to one another. In still other embodiments, inner and outer tubular member 28/30 may be adjacent to and substantially parallel to one another so that they are non-overlapping. In these embodiments, shaft 18 may include an outer sheath that is disposed over tubular members 28/30.
Inner tubular member 28 may include an inner lumen 32. In at least some embodiments, inner lumen 32 is a guidewire lumen. Accordingly, catheter 10 can be advanced over a guidewire to the desired location. The guidewire lumen may extend along essentially the entire length of catheter shaft 18 so that catheter 10 resembles traditional “over-the-wire” catheters. Alternatively, the guidewire lumen may extend along only a portion of shaft 18 so that catheter 10 resembles “single-operator-exchange” or “rapid-exchange” catheters.
In some embodiments, one or more marker members 33 may be coupled to catheter 10. Marker members 33 may include, be made from, be doped with, or otherwise include a radiopaque material. Radiopaque materials are understood to be materials capable of producing a relatively bright image on a fluoroscopy screen or another imaging technique during a medical procedure. This relatively bright image aids the user of catheter 10 in determining its location. Some examples of radiopaque materials can include, but are not limited to, gold, platinum, palladium, tantalum, tungsten alloy, plastic material loaded with a radiopaque filler, and the like.
Shaft 18 may also include an inflation lumen 34 that is in fluid communication with chambers 24 and may be used, for example, to transport inflation media to and from chambers 24 and/or balloon 16. The location and position of inflation lumen 34 may vary, depending on the configuration of tubular members 28/30. For example, when outer tubular member 30 is disposed over inner tubular member 28, inflation lumen 34 may be defined within the space between tubular members 28/30. Moreover, depending on the position of inner tubular member 28 within outer tubular member 30, the shape of lumen 34 (i.e., the shape adjacent shaft 18) may vary. For example, if inner tubular member 28 is attached to or disposed adjacent to the inside surface of outer tubular member 30, then inflation lumen 34 may be generally half-moon in shape; whereas if inner tubular member 28 is generally coaxial with outer tubular member 30, then inflation lumen 34 may be generally ring-shaped or annular in shape. It can be appreciated that if outer tubular member 30 is disposed alongside inner tubular member 28, then lumen 34 may be the lumen of outer tubular member 30 or it may be the space defined between the outer surface of tubular members 28/30 and the outer sheath disposed thereover.
Balloon 16 may be coupled to catheter shaft 18 in any of a number of suitable ways. For example, balloon 16 may be adhesively or thermally bonded to shaft 18. In some embodiments, a proximal portion 36 of balloon 16 may be bonded to shaft 18, for example, at outer tubular member 30, and a distal portion 38 may be bonded to shaft 18, for example, at inner tubular member 28. The exact bonding positions, however, may vary. It can be appreciated that a section of proximal portion 36 may not have sections 26 extending therefrom in order for suitable bonding between balloon 16 and outer tubular member 30. A folding spring (not shown) may be coupled to balloon 16, for example, adjacent proximal portion 36, which may further help in balloon folding and refolding. A description of a suitable folding spring can be found in U.S. Pat. No. 6,425,882, which is incorporated herein by reference. A2/////
Another cross-sectional view of balloon 16 is shown in
A cross-sectional view of another example balloon 116, suitable for use with catheter 10 and other medical devices, is shown in
Another example balloon 416 is shown in
The balloon tubes 516 or 616 are used to form balloons of preferred embodiments of the present invention. The balloon tube is placed within a mold chamber that has a preferred exterior shape for the balloon. The balloon tube is heated and expanded utilizing a gas or liquid such that the expanded chambers are formed from the lumens 524 or 624. The wall thicknesses of the balloon material surrounding the lumens are selected such that thinning occurs during expansion in the mold, but not to a degree that compromises burst pressure of the final balloon product. The various balloon tube lumens may be inflated individually or simultaneously to form final chambers of desired dimension in the overall balloon cross section.
As stated above, including a plurality of chambers in the balloon with dividing sections extending radially between chambers may help to reduce balloon elongation. Additionally, the chambers and walls between the chambers may also be desirable by facilitating re-folding. For example, the chambers can be vented by pulling vacuum or other means so as to partially collapse the balloon which will preferentially fold first at the thinner areas between dividing sections. At these creases, the balloon can more easily and consistently re-fold when the entire balloon is deflated. By placing the cutting blades to extend longitudinally at a circumferential position between the wall dividing sections or chambers, the cutting blades will be preferentially drawn radially inward away from the vessel wall during deflation. In some preferred embodiments, the blades are positioned at about the circumferential mid-point between adjacent walls forming a chamber as depicted in
It should be understood that this disclosure is, in many respects, only illustrative. Changes may be made in details, particularly in matters of shape, size, and arrangement of steps without exceeding the scope of the invention. The invention's scope is, of course, defined in the language in which the appended claims are expressed.
Number | Name | Date | Kind |
---|---|---|---|
2816552 | Hoffman | Dec 1957 | A |
3174851 | Buehler et al. | Mar 1965 | A |
3351463 | Rozner et al. | Nov 1967 | A |
3635223 | Klieman | Jan 1972 | A |
3749085 | Willson et al. | Jul 1973 | A |
3753700 | Harrison et al. | Aug 1973 | A |
3990453 | Douvas et al. | Nov 1976 | A |
4140126 | Choudhury | Feb 1979 | A |
4141364 | Schultze | Feb 1979 | A |
4263236 | Briggs et al. | Apr 1981 | A |
4273128 | Lary | Jun 1981 | A |
4292974 | Fogarty et al. | Oct 1981 | A |
4406656 | Hattler et al. | Sep 1983 | A |
4465072 | Taheri | Aug 1984 | A |
4490421 | Levy | Dec 1984 | A |
4572186 | Gould et al. | Feb 1986 | A |
4574781 | Chin | Mar 1986 | A |
4608984 | Fogarty | Sep 1986 | A |
4627436 | Leckrone | Dec 1986 | A |
4685458 | Leckrone | Aug 1987 | A |
4686982 | Nash | Aug 1987 | A |
4696667 | Masch | Sep 1987 | A |
4705517 | DiPisa, Jr. | Nov 1987 | A |
4723549 | Wholey et al. | Feb 1988 | A |
4728319 | Masch | Mar 1988 | A |
4747405 | Leckrone | May 1988 | A |
4748982 | Horzewski et al. | Jun 1988 | A |
4784636 | Rydell | Nov 1988 | A |
4787388 | Hofmann | Nov 1988 | A |
4790813 | Kensey | Dec 1988 | A |
4793348 | Palmaz | Dec 1988 | A |
4796629 | Grayzel | Jan 1989 | A |
4799479 | Spears | Jan 1989 | A |
RE32983 | Levy | Jul 1989 | E |
4886061 | Fischell et al. | Dec 1989 | A |
4921483 | Wijay et al. | May 1990 | A |
4921484 | Hillstead | May 1990 | A |
4936845 | Stevens | Jun 1990 | A |
4966604 | Reiss | Oct 1990 | A |
RE33561 | Levy | Mar 1991 | E |
5009659 | Hamlin et al. | Apr 1991 | A |
5030201 | Palestrant | Jul 1991 | A |
5042985 | Elliott et al. | Aug 1991 | A |
5047040 | Simpson et al. | Sep 1991 | A |
5049132 | Shaffer et al. | Sep 1991 | A |
5078722 | Stevens | Jan 1992 | A |
5078725 | Enderle et al. | Jan 1992 | A |
5085662 | Willard | Feb 1992 | A |
5087265 | Summers | Feb 1992 | A |
5100424 | Jang et al. | Mar 1992 | A |
5100425 | Fischell et al. | Mar 1992 | A |
5102390 | Crittenden et al. | Apr 1992 | A |
5116318 | Hillstead | May 1992 | A |
5135482 | Neracher | Aug 1992 | A |
5152773 | Redha | Oct 1992 | A |
5156594 | Keith | Oct 1992 | A |
5156610 | Reger | Oct 1992 | A |
5158564 | Schnepp-Pesch et al. | Oct 1992 | A |
5176693 | Pannek, Jr. | Jan 1993 | A |
5180368 | Garrison | Jan 1993 | A |
5196024 | Barath | Mar 1993 | A |
5197965 | Cherry et al. | Mar 1993 | A |
5209749 | Buelna | May 1993 | A |
5209799 | Vigil | May 1993 | A |
5226430 | Spears et al. | Jul 1993 | A |
5226887 | Farr et al. | Jul 1993 | A |
5248311 | Black et al. | Sep 1993 | A |
5250059 | Andreas et al. | Oct 1993 | A |
5254089 | Wang | Oct 1993 | A |
5300025 | Wantink | Apr 1994 | A |
5308323 | Sogawa et al. | May 1994 | A |
5318576 | Plassche, Jr. et al. | Jun 1994 | A |
5320634 | Vigil et al. | Jun 1994 | A |
5328472 | Steinke et al. | Jul 1994 | A |
5336234 | Vigil et al. | Aug 1994 | A |
5372601 | Lary | Dec 1994 | A |
5395361 | Fox et al. | Mar 1995 | A |
5411466 | Hess | May 1995 | A |
5415654 | Daikuzono | May 1995 | A |
5417653 | Sahota et al. | May 1995 | A |
5417703 | Brown et al. | May 1995 | A |
5425711 | Ressemann et al. | Jun 1995 | A |
5437659 | Leckrone | Aug 1995 | A |
5441510 | Simpson et al. | Aug 1995 | A |
5456681 | Hajjar | Oct 1995 | A |
5470415 | Perkins et al. | Nov 1995 | A |
5496308 | Brown et al. | Mar 1996 | A |
5507760 | Wynne et al. | Apr 1996 | A |
5507761 | Duer | Apr 1996 | A |
5522818 | Keith et al. | Jun 1996 | A |
5522825 | Kropf et al. | Jun 1996 | A |
5549556 | Ndondo-Lay et al. | Aug 1996 | A |
5569195 | Saab | Oct 1996 | A |
5569277 | Evans et al. | Oct 1996 | A |
5571087 | Ressemann et al. | Nov 1996 | A |
5616149 | Barath | Apr 1997 | A |
5628761 | Rizik | May 1997 | A |
5643296 | Hundertmark et al. | Jul 1997 | A |
5645529 | Fagan et al. | Jul 1997 | A |
5681336 | Clement et al. | Oct 1997 | A |
5713913 | Lary et al. | Feb 1998 | A |
5718684 | Gupta | Feb 1998 | A |
5720724 | Ressemann et al. | Feb 1998 | A |
5792105 | Lin et al. | Aug 1998 | A |
5797935 | Barath | Aug 1998 | A |
5814016 | Valley et al. | Sep 1998 | A |
5827201 | Samson et al. | Oct 1998 | A |
5860954 | Ropiak | Jan 1999 | A |
5895402 | Hundertmark et al. | Apr 1999 | A |
5931819 | Fariabi | Aug 1999 | A |
6024722 | Rau et al. | Feb 2000 | A |
6039699 | Viera | Mar 2000 | A |
6066149 | Samson et al. | May 2000 | A |
6068623 | Zadno-Azizi et al. | May 2000 | A |
6139510 | Palermo | Oct 2000 | A |
6142975 | Jalisi et al. | Nov 2000 | A |
6165140 | Ferrera | Dec 2000 | A |
6165167 | Delaloye | Dec 2000 | A |
6165292 | Abrams et al. | Dec 2000 | A |
6168571 | Solar et al. | Jan 2001 | B1 |
6190332 | Muni et al. | Feb 2001 | B1 |
6193686 | Estrada et al. | Feb 2001 | B1 |
6217549 | Selmon et al. | Apr 2001 | B1 |
6217567 | Zadno-Azizi et al. | Apr 2001 | B1 |
6241690 | Burkett et al. | Jun 2001 | B1 |
6254550 | McNamara et al. | Jul 2001 | B1 |
6306105 | Rooney et al. | Oct 2001 | B1 |
6344029 | Estrada et al. | Feb 2002 | B1 |
6355016 | Bagaoisan et al. | Mar 2002 | B1 |
6379362 | Birk et al. | Apr 2002 | B1 |
6383146 | Klint | May 2002 | B1 |
6387075 | Stivland et al. | May 2002 | B1 |
6398798 | Selmon et al. | Jun 2002 | B2 |
6409863 | Williams et al. | Jun 2002 | B1 |
6425882 | Vigil | Jul 2002 | B1 |
6458076 | Pruitt | Oct 2002 | B1 |
6471673 | Kasterhofer | Oct 2002 | B1 |
6533754 | Hisamatsu et al. | Mar 2003 | B1 |
6544276 | Azizi | Apr 2003 | B1 |
7008438 | O'Brien | Mar 2006 | B2 |
Number | Date | Country |
---|---|---|
34 00 416 | Jul 1985 | DE |
3402573 | Aug 1985 | DE |
35 19 626 | Dec 1986 | DE |
0 291 170 | Nov 1988 | EP |
0 414 350 | Feb 1991 | EP |
1 547 328 | Jun 1979 | GB |
WO 9007909 | Jul 1990 | WO |
WO 9117714 | Nov 1991 | WO |
Number | Date | Country | |
---|---|---|---|
20050038383 A1 | Feb 2005 | US |